Stephen D. Griffin

CIK: 0001831125

Transaction Breakdown

Open Market Buys (P)1 (8.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (25.0%)

Derivative conversions

Awards (A)5 (41.7%)

Compensation grants

Other (G, F, J, C, D, …)3 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ANIK

Anika Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

ANIK
Anika Therapeutics, Inc.
Jun 3, 2026
Tax Payment(F)
Direct
3.8K shares at avg. $14.41$54K
ANIK
Anika Therapeutics, Inc.
Jun 3, 2026
Exercise(M)
Direct
12.8K shares-
ANIK
Anika Therapeutics, Inc.
Apr 30, 2026
Purchase(P)
Direct
12.2K shares at avg. $12.29$150K
ANIK
Anika Therapeutics, Inc.
Mar 14, 2026
Exercise(M)
Direct
12.8K shares-
ANIK
Anika Therapeutics, Inc.
Mar 14, 2026
Award(A)
Direct
6.4K shares-
ANIK
Anika Therapeutics, Inc.
Mar 14, 2026
Tax Payment(F)
Direct
5.9K shares at avg. $14.20$84K
ANIK
Anika Therapeutics, Inc.
Feb 1, 2026
Award(A)
Restricted Stock Unit
Direct
130.4K shares-
ANIK
Anika Therapeutics, Inc.
Feb 1, 2026
Award(A)
Stock Appreciation Rights
Direct
310.2K shares-
ANIK
Anika Therapeutics, Inc.
Jun 3, 2025
Exercise(M)
Direct
12.8K shares-
ANIK
Anika Therapeutics, Inc.
Jun 3, 2025
Tax Payment(F)
Direct
3.8K shares at avg. $11.59$44K
ANIK
Anika Therapeutics, Inc.
Mar 14, 2025
Award(A)
Restricted Stock Unit
Direct
38.5K shares-
ANIK
Anika Therapeutics, Inc.
Mar 14, 2025
Award(A)
Restricted Stock Unit
Direct
18.7K shares-

		Type	Shares	Price		Ownership
Jun 3, 2026	ANIK Anika Therapeutics, Inc.	Tax Payment(F)	3,769	$14.41	$54,311	Direct
Jun 3, 2026	ANIK Anika Therapeutics, Inc.	Exercise(M)	12,840	-	$0	Direct
Apr 30, 2026	ANIK Anika Therapeutics, Inc.	Purchase(P)	12,200	$12.29	$149,881	Direct
Mar 14, 2026	ANIK Anika Therapeutics, Inc.	Exercise(M)	12,824	-	$0	Direct
Mar 14, 2026	ANIK Anika Therapeutics, Inc.	Award(A)	6,412	-	$0	Direct
Mar 14, 2026	ANIK Anika Therapeutics, Inc.	Tax Payment(F)	5,944	$14.20	$84,405	Direct
Feb 1, 2026	ANIK Anika Therapeutics, Inc.	Award(A) Restricted Stock Unit	130,402	-	-	Direct
Feb 1, 2026	ANIK Anika Therapeutics, Inc.	Award(A) Stock Appreciation Rights	310,207	-	-	Direct
Jun 3, 2025	ANIK Anika Therapeutics, Inc.	Exercise(M)	12,840	-	-	Direct
Jun 3, 2025	ANIK Anika Therapeutics, Inc.	Tax Payment(F)	3,769	$11.59	$43,683	Direct
Mar 14, 2025	ANIK Anika Therapeutics, Inc.	Award(A) Restricted Stock Unit	38,473	-	-	Direct
Mar 14, 2025	ANIK Anika Therapeutics, Inc.	Award(A) Restricted Stock Unit	18,672	-	-	Direct

1-12 of 12 transactions

About Griffin Stephen D.

Griffin Stephen D. (SEC CIK 0001831125) files insider reports with the SEC as President and CEO of Anika Therapeutics, Inc. (ANIK).

Signal8 holds 6 ownership filings by Griffin Stephen D., all Form 4s, filed between Mar 18, 2025 and Jun 5, 2026. Those filings report 12 transactions, from Mar 14, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Griffin Stephen D.'s filings is in BEDFORD, MA.

Recent filings by Griffin Stephen D.

Jun 3, 2026: Tax withholding of ANIK shares (Form 4, code F).
Jun 3, 2026: Option exercise of ANIK shares (Form 4, code M).
Apr 30, 2026: Open-market purchase of ANIK shares (Form 4, code P).
Mar 14, 2026: Option exercise of ANIK shares (Form 4, code M).
Mar 14, 2026: Grant or award of ANIK shares (Form 4, code A).

Other insiders filing for Anika Therapeutics, Inc. (ANIK)

Fischetti Gary P, Director
HENNEMAN JOHN B III, Director
Richard Stephen, Director
Capper Joseph H, Director
CONLEY SHERYL L, Director
McLeod Ian, SVP, CAO & Treasurer

How to read Form 4 transaction codes